Biosimilars have provided many challenges and opportunities in equal measure for innovators and applicants. Biosimilars-2012 is designed to discuss the development and progress of research in the areas of drug discovery, clinical trials, regulatory and economic considerations towards Biosimilars and Biowaivers.
Biosimilars-2012 is a remarkable event which brings together a unique and International mix of large and medium Pharmaceutical and Biotech companies, leading universities and Pharmacological research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.